Name (Synonyms) | Correlation | |
---|---|---|
drug837 | The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: Wiki | 0.71 |
drug125 | Biosensors Wiki | 0.71 |
Name (Synonyms) | Correlation | |
---|---|---|
D006470 | Hemorrhage NIH | 0.71 |
D006929 | Hyperaldosteronism NIH | 0.71 |
D014552 | Urinary Tract Infections NIH | 0.71 |
D000309 | Adrenal Insufficiency NIH | 0.71 |
D054559 | Hyperphosphatemia NIH | 0.71 |
D007008 | Hypokalemia NIH | 0.71 |
D001997 | Bronchopulmonary Dysplasia NIH | 0.71 |
D008595 | Menorrhagia NIH | 0.71 |
D006973 | Hypertension NIH | 0.63 |
D003141 | Communicable Diseases NIH | 0.08 |
D007239 | Infection NIH | 0.06 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0000132 | Menorrhagia HPO | 0.71 |
HP:0002900 | Hypokalemia HPO | 0.71 |
HP:0000859 | Hyperaldosteronism HPO | 0.71 |
HP:0000846 | Adrenal insufficiency HPO | 0.71 |
There are 2 clinical trials
There are currently no clinical studies reporting clinical characteristics difference between the hypertension patients with and without ACEI treatment when suffered with novel coronavirus infection in China.
Description: The percentage of patients admitted to the ICU at any time during the 28 days of onset COVID-19.
Measure: Occupancy rate in the intensive care unit (ICU) Time: up to 28 daysDescription: The number of patients requiring mechanical ventilation.
Measure: Mechanical Ventilation Time: up to 28 daysDescription: The number of patients who died of 2019-nCoV infection.
Measure: Death Time: up to 28 daysDescription: The number of died 2019-nCoV infected patients from any cause.
Measure: All cause mortality Time: up to 28 daysDescription: Time from onset of symptoms to admitted to the ICU, requiring mechanical ventilation, and death.
Measure: Time from onset of symptoms to main outcome and its components Time: up to 28 daysDescription: Time to Clinical Recovery
Measure: Time to Clinical Recovery Time: up to 28 daysThe study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK of understudied drugs currently being administered to children per SOC as prescribed by their treating provider.